Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PHAT
PHAT logo

PHAT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PHAT News

Barclays Upgrades Phathom to Overweight Amid Sales Recovery Prospects

Mar 27 2026seekingalpha

PHATHOM PHARMACEUTICALS INC.: BARCLAYS INCREASES TARGET PRICE FROM $16 TO $18

Mar 27 2026moomoo

Surge in Options Trading Volume for Adobe and Phathom Pharmaceuticals

Mar 19 2026NASDAQ.COM

Emerging Trends in H. pylori Infection Market

Mar 04 2026Newsfilter

Phathom Pharmaceuticals Q4 2025 Earnings Call Highlights

Feb 26 2026seekingalpha

Phathom Pharmaceuticals Set to Announce Q4 Earnings

Feb 25 2026seekingalpha

Phathom Pharmaceuticals Sees Q4 Sales of $57-58M, Prices $130M Public Offering

Jan 08 2026Benzinga

Northrop Grumman Shares Rise 6.84% Following Military Budget Proposal

Jan 08 2026Benzinga

PHAT Events

No data

No data

PHAT Monitor News

Phathom Pharmaceuticals shares drop after public offering announcement

Jan 08 2026

PHAT Earnings Analysis

No Data

No Data

People Also Watch